SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
SEC Accession No. 0001104659-17-009402
Filing Date
2017-02-15
Accepted
2017-02-14 18:14:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 FWP a17-4066_5fwp.htm FWP 105064
2 GRAPHIC g40664bai001.jpg GRAPHIC 4296
  Complete submission text file 0001104659-17-009402.txt   112600
Mailing Address 608 FIFTH AVENUE NEW YORK NY 10020
Business Address 608 FIFTH AVENUE NEW YORK NY 10020 (212)307 1122
Novartis Capital CORP (Filed by) CIK: 0001443411 (see all company filings)

IRS No.: 263086456 | State of Incorp.: DE | Fiscal Year End: 1231
Type: FWP
SIC: 2834 Pharmaceutical Preparations

Mailing Address 608 FIFTH AVENUE NEW YORK NY 10020
Business Address 608 FIFTH AVENUE NEW YORK NY 10020 (212)307 1122
Novartis Capital CORP (Subject) CIK: 0001443411 (see all company filings)

IRS No.: 263086456 | State of Incorp.: DE | Fiscal Year End: 1231
Type: FWP | Act: 34 | File No.: 333-207004-02 | Film No.: 17611861
SIC: 2834 Pharmaceutical Preparations